These observations are in agreement with previous comparisons between the ReaScan CXCL13 assay and enzyme-linked immunosorbent assays including non-LNB populations comprising a mix of patients with and without CFS pleocytosis [18, 19]. The gene discussed is CXCL13; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.